Skip to main content

Relapsed or Refractory Multiple Myeloma SUCCESSOR-2

Status: Completed

Study Details

View study details on www.clinicaltrials.gov.

Locations

  • Santa Rosa

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of RRMM: SUCCESSOR-2.

Zeyad H. Kanaan
Zeyad H. Kanaan
Principal investigator
View Profile

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?